The manuscript discussed the possible roles of histone methylation in Huntington's disease and the influence of manipulating this pathway effectively affected the outcome of Huntington's disease in different models. The review of histone methylation is broad. It addressed major findings in Huntington's research in terms of histone methylation and possibility of intervention these targets. However, here is some concerns. The title seems inadequate using the word "compromised". The pathogenic role may results from improper activation/repression of modification/methylation of different histones or even same histone. In page 5 and 6, you discussed a lot about different component of H3K27me3 specific methyltransferase complex, especially PRC2. How specific is PRC2 in Huntington's disease. Is the PRC2 impairment mutant huntingtin specific or it is general for neurodegenerative disorders? For other components, there is similar concern. How specific are these components to mutant huntingtin? 
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COMMENTS TO AUTHORS
Strengths: Timely, well-written Weaknesses: not much novelty, reads closer to two summaries of two manuscripts, not a global outlook on the field.
The paper is a concise summary of two recently published manuscripts regarding methylation status in HD cells and mouse models. While no information is novel, the authors provide an interesting perspective on the published work. The review and article present
